1. Home
  2. BLND vs WVE Comparison

BLND vs WVE Comparison

Compare BLND & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLND
  • WVE
  • Stock Information
  • Founded
  • BLND 2012
  • WVE 2012
  • Country
  • BLND United States
  • WVE Singapore
  • Employees
  • BLND N/A
  • WVE N/A
  • Industry
  • BLND EDP Services
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLND Technology
  • WVE Health Care
  • Exchange
  • BLND Nasdaq
  • WVE Nasdaq
  • Market Cap
  • BLND 899.9M
  • WVE 915.6M
  • IPO Year
  • BLND 2021
  • WVE 2015
  • Fundamental
  • Price
  • BLND $3.38
  • WVE $7.15
  • Analyst Decision
  • BLND Buy
  • WVE Strong Buy
  • Analyst Count
  • BLND 6
  • WVE 16
  • Target Price
  • BLND $4.88
  • WVE $20.19
  • AVG Volume (30 Days)
  • BLND 3.2M
  • WVE 1.9M
  • Earning Date
  • BLND 11-05-2025
  • WVE 11-11-2025
  • Dividend Yield
  • BLND N/A
  • WVE N/A
  • EPS Growth
  • BLND N/A
  • WVE N/A
  • EPS
  • BLND N/A
  • WVE N/A
  • Revenue
  • BLND $167,776,000.00
  • WVE $93,946,000.00
  • Revenue This Year
  • BLND N/A
  • WVE N/A
  • Revenue Next Year
  • BLND $27.00
  • WVE $6.85
  • P/E Ratio
  • BLND N/A
  • WVE N/A
  • Revenue Growth
  • BLND 29.83
  • WVE N/A
  • 52 Week Low
  • BLND $2.64
  • WVE $5.28
  • 52 Week High
  • BLND $5.53
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • BLND 36.37
  • WVE 43.62
  • Support Level
  • BLND $3.71
  • WVE $6.91
  • Resistance Level
  • BLND $3.86
  • WVE $7.48
  • Average True Range (ATR)
  • BLND 0.21
  • WVE 0.31
  • MACD
  • BLND -0.10
  • WVE 0.08
  • Stochastic Oscillator
  • BLND 4.29
  • WVE 63.74

About BLND Blend Labs Inc.

Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: